BSEBoard Meeting13h ago · 26 Oct 2026, 03:52 pm
Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2026.
Abbott India Ltd · 500488
✦ AI SummaryResults
Abbott India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/11/2026 to consider and approve the Unaudited Financial Results for the second quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Abbott India Ltd - 500488 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2026
Attachments (1)
📄pdf
Download →
2383cb12-5c44-4fd6-b903-3cc732785d36.pdf
View document text
Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000
Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400
15-16th Floor, Bandra-Kurla Complex, Sion Trombay Road, E-mail : webmasterindia@abbott.com
Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in
Mumbai - 400 051. India CIN: L24239MH1944PLC007330
October 26, 2026
BSE Limited
Corporate Relationship Department
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai 400 001
Scrip Code: 500488
Dear Sir/Madam,
Subject: Intimation under Regulation 29 (1) (a) of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
In terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a
Meeting of the Board of Directors of the Company is scheduled to be held on Thursday,
November 5, 2026, inter alia, to consider and approve the Unaudited Financial Results of
the Company for the second quarter and half year ended September 30, 2026.
Please note that in terms of Abbott India Code of Internal Procedures and Conduct for
Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the
provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading)
Regulations, 2015 and further to our intimation dated September 28, 2026, the Trading
Window of the Company remains closed from Thursday, October 1, 2026, to Saturday,
November 7, 2026 (both days inclusive).
Kindly acknowledge the receipt of the same.
For Abbott India Limited
Sangeeta Shetty
Company Secretary
Membership No.: ACS 18865
Cc: National Securities Depository Limited
Central Depository Services (India) Limited